FDA clears Siemens mammo system aimed at small to mid-size hospitals

Evan Godt | | Health Imaging | Screening

Siemens Healthcare has announced that the FDA cleared the company’s latest full-field digital mammography system, the Mammomat Fusion.

In the announcement, Siemens said the system was designed to meet the specific needs of the midrange price segment at small to medium-sized hospitals.

The Mammomat Fusion includes a number of features aimed at reducing radiation dose to patients, according to the company. The system features a new generation cesium-iodide detector that enables more efficient utilization of radiation. It also includes the OpDose feature, developed for Siemens’ premium Mammomat Inspiration platform, which allows users to tailor dose according to patient breast size and density.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Related Content

What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise
Singing radiologist pens song to clear up confusion about breast cancer screening recs
AI loaded onto mammography systems can flag possible cancers in real time to speed workflows

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.